Showing results (421-430 of 465) with videos related to
Sort By:
Pageof 47
Npj Health Systems|February 19, 2026
Accelerating AI innovation in healthcare: real-world clinical research applications on the Mayo Clinic PlatformYue Yu, Xinyue Hu, Sivaraman Rajaganapathy, et al.Journal of Neurosurgery|January 22, 2026
Race, socioeconomic status, and geography influence utilization of surgery in Minnesota epilepsy patientsJameson Moore, James Jean, Jacob Hanson, et al.Neurosurgery|September 17, 2016
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With Nonfunctioning Pituitary AdenomasMateo Ziu, Ian F Dunn, Christopher Hess, et al.Nature Biotechnology|October 18, 2024
Droplet Hi-C enables scalable, single-cell profiling of chromatin architecture in heterogeneous tissuesLei Chang, Yang Xie, Brett Taylor, et al.Pain Medicine (Malden, Mass.)|January 28, 2016
Is There a Relationship Between Body Mass Index and Fluoroscopy Time During Sacroiliac Joint Injection? A Multicenter Cohort StudyZachary L McCormick, Daniel Cushman, David T Lee, et al.Oncotarget|October 6, 2017
A cerebrospinal fluid microRNA signature as biomarker for glioblastomaJohnny C Akers, Wei Hua, Hongying Li, et al.Proceedings of the National Academy of Sciences of the United States of America|July 11, 2015
Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expressionDavid Kozono, Jie Li, Masayuki Nitta, et al.Oncotarget|June 11, 2015
Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibitionYing Shen, Jie Li, Masayuki Nitta, et al.Neuro-Oncology|July 11, 2026
iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engagerJian-Fang Ning, Zachary B Davis, Qudsia Zeb, et al.Eclinicalmedicine|March 5, 2026
Tumor antigen only (TAO) vaccine platforms for glioblastoma therapeutics: a systematic review of evidence from clinical trialsHsien-Chung Chen, Eric T Wong, Sasmit Sarangi, et al.Pageof 47